Potocki, P.M.; Wójcik, P.; Chmura, Ł.; Goc, B.; Fedewicz, M.; Bielańska, Z.; Swadźba, J.; Konopka, K.; Kwinta, Ł.; Wysocki, P.J.
Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study. Int. J. Mol. Sci. 2023, 24, 9073.
https://doi.org/10.3390/ijms24109073
AMA Style
Potocki PM, Wójcik P, Chmura Ł, Goc B, Fedewicz M, Bielańska Z, Swadźba J, Konopka K, Kwinta Ł, Wysocki PJ.
Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study. International Journal of Molecular Sciences. 2023; 24(10):9073.
https://doi.org/10.3390/ijms24109073
Chicago/Turabian Style
Potocki, Paweł M., Piotr Wójcik, Łukasz Chmura, Bartłomiej Goc, Marcin Fedewicz, Zofia Bielańska, Jakub Swadźba, Kamil Konopka, Łukasz Kwinta, and Piotr J. Wysocki.
2023. "Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study" International Journal of Molecular Sciences 24, no. 10: 9073.
https://doi.org/10.3390/ijms24109073
APA Style
Potocki, P. M., Wójcik, P., Chmura, Ł., Goc, B., Fedewicz, M., Bielańska, Z., Swadźba, J., Konopka, K., Kwinta, Ł., & Wysocki, P. J.
(2023). Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study. International Journal of Molecular Sciences, 24(10), 9073.
https://doi.org/10.3390/ijms24109073